Chordia Therapeutics Ratios and Metrics

Market cap in millions JPY. Fiscal year is September - August.

Millions JPY. Fiscal year is Sep - Aug.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Mar '26 Mar 9, 2026	Aug '25 Aug 31, 2025	Aug '24 Aug 31, 2024	Aug '23 Aug 31, 2023
Market Capitalization	9,043	12,418	51,534	-
Market Cap Growth	-49.78%	-75.90%	-	-
Enterprise Value	6,707	9,596	48,276	-
Last Close Price	124.00	180.00	780.00	-
PB Ratio	3.94	5.10	12.38	-
P/TBV Ratio	3.94	5.10	12.39	-
Net Debt / Equity Ratio	-1.02	-1.05	-1.04	-1.07
Net Debt / EBITDA Ratio	1.59	1.43	2.41	-22.00
Net Debt / FCF Ratio	-	1.38	2.23	-8.83
Quick Ratio	12.72	10.43	9.19	11.76
Current Ratio	13.43	10.92	9.78	11.98
Return on Equity (ROE)	-49.97%	-54.13%	-42.19%	-
Return on Assets (ROA)	-29.37%	-30.59%	-23.60%	-
Return on Capital Employed (ROCE)	-64.10%	-73.40%	-43.30%	4.70%
Earnings Yield	-16.20%	-14.38%	-3.55%	-
FCF Yield	-	-14.84%	-3.76%	-
Buyback Yield / Dilution	-12.02%	-16.82%	-4.05%	-

Updated Nov 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.